Aurobindo To Set Up Exclusive Hyd Plant
  • Prabha Hedge
  • Mar 06 2014

March 6: Following Aurobindo Pharma's Rs.220 crore deal to acquire Actavis’ Western European operations, sources tell Bloomberg TV India that the company now plans to set up another drug facility in Hyderabad. The move has been strategically planned so that it can cut costs and also manufacture some of Actavis’ products domestically. The transfer of licenses is expected to be completed in six months. Priya Sheth shares a detailed report on the same.